Compare DUOT & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DUOT | MIST |
|---|---|---|
| Founded | 1990 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 220.5M | 176.3M |
| IPO Year | N/A | N/A |
| Metric | DUOT | MIST |
|---|---|---|
| Price | $10.99 | $2.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $14.00 | $8.50 |
| AVG Volume (30 Days) | 193.6K | ★ 9.9M |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,026,308.00 | N/A |
| Revenue This Year | $292.26 | N/A |
| Revenue Next Year | $43.21 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 159.00 | N/A |
| 52 Week Low | $3.84 | $0.63 |
| 52 Week High | $12.17 | $3.06 |
| Indicator | DUOT | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 58.98 | 42.62 |
| Support Level | $9.25 | $1.94 |
| Resistance Level | $12.17 | $2.14 |
| Average True Range (ATR) | 0.67 | 0.29 |
| MACD | 0.16 | -0.04 |
| Stochastic Oscillator | 61.04 | 29.66 |
Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains that are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).